| For: | Liu W, Yu ZC, Cao WF, Ding F, Liu ZH. Functional studies of a novel oncogene TGM3 in human esophageal squamous cell carcinoma. World J Gastroenterol 2006; 12(24): 3929-3932 [PMID: 16804985 DOI: 10.3748/wjg.v12.i24.3929] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i24/3929.htm |
| Number | Citing Articles |
| 1 |
Jin-Wu Hu, Zhang-fu Yang, Jia Li, Bo Hu, Chu-Bin Luo, Kai Zhu, Zhi Dai, Jia-Bin Cai, Hao Zhan, Zhi-Qiang Hu, Jie Hu, Ya Cao, Shuang-Jian Qiu, Jian Zhou, Jia Fan, Xiao-Wu Huang. TGM3 promotes epithelial–mesenchymal transition and hepatocellular carcinogenesis and predicts poor prognosis for patients after curative resection. Digestive and Liver Disease 2020; 52(6) doi: 10.1016/j.dld.2019.10.010
|
| 2 |
Rita Rani Roy, Katsumitsu Shimada, Satoshi Murakami, Hiromasa Hasegawa. Contribution of transglutaminases and their substrate proteins to the formation of cornified cell envelope in oral mucosal epithelium. European Journal of Oral Sciences 2021; 129(1) doi: 10.1111/eos.12760
|
| 3 |
Wei Li, Zhongmian Zhang, Wenchao Zhao, Na Han. Transglutaminase 3 protein modulates human esophageal cancer cell growth by targeting the NF-κB signaling pathway. Oncology Reports 2016; 36(3) doi: 10.3892/or.2016.4921
|
| 4 |
Norihisa Uemura, Yukihiro Nakanishi, Hoichi Kato, Shigeru Saito, Masato Nagino, Setsuo Hirohashi, Tadashi Kondo. Transglutaminase 3 as a prognostic biomarker in esophageal cancer revealed by proteomics. International Journal of Cancer 2009; 124(9) doi: 10.1002/ijc.24194
|
| 5 |
Hongyun Gao, Lishan Wang, Shitao Cui, Mingsong Wang. Combination of meta-analysis and graph clustering to identify prognostic markers of ESCC. Genetics and Molecular Biology 2012; 35(2) doi: 10.1590/S1415-47572012000300021
|
| 6 |
Ayako Negishi, Mari Masuda, Masaya Ono, Kazufumi Honda, Miki Shitashige, Reiko Satow, Tomohiro Sakuma, Hideya Kuwabara, Yukihiro Nakanishi, Yae Kanai, Ken Omura, Setsuo Hirohashi, Tesshi Yamada. Quantitative proteomics using formalin‐fixed paraffin‐embedded tissues of oral squamous cell carcinoma. Cancer Science 2009; 100(9) doi: 10.1111/j.1349-7006.2009.01227.x
|
| 7 |
Judith Boone, Richard van Hillegersberg, Paul J. van Diest, G. Johan A. Offerhaus, Inne H. M. Borel Rinkes, Fiebo J. W. Ten Kate. Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Archiv 2008; 452(5) doi: 10.1007/s00428-008-0602-0
|
| 8 |
Xiangbing Wu, Wei Cao, Xu Wang, Jianjun Zhang, Zhongjing Lv, Xing Qin, Yadi Wu, Wantao Chen. TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Molecular Cancer 2013; 12(1) doi: 10.1186/1476-4598-12-151
|
| 9 |
Elif Kubat Öktem, Metin Yazar, Gizem Gulfidan, Kazim Yalcin Arga.
Cancer Drug Repositioning by Comparison of Gene Expression in Humans and Axolotl (
Ambystoma mexicanum
) During Wound Healing
. OMICS: A Journal of Integrative Biology 2019; 23(8) doi: 10.1089/omi.2019.0093
|
| 10 |
Li-li Pan, Yuan-mao Huang, Min Wang, Xiao-e Zhuang, Dong-feng Luo, Shi-cheng Guo, Zhi-shun Zhang, Qing Huang, Sheng-long Lin, Shao-yuan Wang. Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia. European Journal of Human Genetics 2015; 23(2) doi: 10.1038/ejhg.2014.67
|